News

News
Partner news

NovoCure, Ltd., Announces the Closing of a Financing Round

Read full story
JNJ Press releases

Ontario Government, University of Toronto, and MaRS secure Johnson & Johnson Innovation, JLABS for Toronto – first JLABS Incubator outside of United States

Read full story
Partner news

Navitor Pharmaceuticals Appoints David M. Madden to Board of Directors and Michael N. Hall, PhD, to Scientific Advisory Board

Read full story
Partner news

Merus Enters into 72.8 million Euro Series C Financing

Read full story
Partner news

Catalyst Biosciences Completes Merger with Targacept and Creates a Protease-Based Hemostasis and Anti-Complement Company

Read full story
Partner news

Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience

Read full story
Partner news

MGD011 Advances into Clinical Development

Read full story
Partner news

Protagonist Therapeutics Raises $40 Million Series C Financing

Read full story
JNJ Press releases

Read the MedCity News Survey on Corporate Venture Capital in Healthcare

Read full story
JNJ Press releases

Lake Whillans Research of VC Strategics in Life Sciences

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Seventeen Collaborations with Focus on Advancing Global Healthcare through Transformational Science and Technologies

Read full story
Partner news

Janssen Enters into a Worldwide Collaboration with Achillion Pharmaceuticals, Inc. to Combat Hepatitis C Virus

Read full story
Partner news

Padlock Therapeutics Assembles Scientific Advisory Board with World Leaders in PAD Enzyme Biology and Autoimmune Disease

Read full story
Partner news

Johnson & Johnson Innovation Commits $15M to Vivo Capital

Read full story